An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Drug Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source.
Several professionals stated the demand for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.
Several influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and customer laws, risking penalties, legal action or prison.
Service Reaction and Material Removal
Based on TikTok, the platform has removed violative content and banned related keywords and search suggestions. The company stated it was committed to maintaining the service safe and investing in enhancing compliance measures.
Online Marketplace Activities
Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
After minutes of joining one group, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.
Item Information and Pricing
Inside these groups, messages show black plastic parcels with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram said it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational product not yet authorized … may subject users to potentially serious medical dangers”.
